MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A case of tardive dyskinesia and parkinsonism following use of phentermine for weight loss

R. Barmore, C. Hess, N. McFarland, M. Okun (Gainesville, FL, USA)

Meeting: 2018 International Congress

Abstract Number: 86

Keywords: Drug-induced parkinsonism(DIP), Tardive dyskinesia(TD)

Session Information

Date: Saturday, October 6, 2018

Session Title: Drug-Induced Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To describe a case of tardive dyskinesia and parkinsonism following use of phentermine and briefly review the literature on tardive syndromes following use of stimulants.

Background: Tardive dyskinesia is a movement disorder characterized by the delayed onset of involuntary muscle movements usually following use of dopaminergic antagonists. It can be associated with several other classes of medications including both prescribed and illicit stimulants. Phentermine is an amphetamine that is approved for weight loss but only with short-term use.

Methods: Case report and review of the literature.

Results: We present the case of a 56-year-old man with a history of depression and obesity who presented with the complaint of unilateral tremor and tongue thrusting. He was on no medication. On exam, his mental status was notable only for impaired delayed recall. He had repetitive tongue thrusts, of which he was unaware. He had a 4-6 Hz resting tremor in his right hand. He had mild bradykinesia and rigidity in his right upper extremity. He had normal strength and sensation throughout. He had no axial or appendicular ataxia. His gait was normal and he had no retropulsion on pull testing. A MRI brain was normal. He had no history of dopamine replacement or dopamine antagonist use. His father had Parkinson’s disease but it occurred late in life. His tongue thrusting and rest tremor had arisen following a 2-month trial of phentermine which was prescribed for weight loss.

Conclusions: This is the second report of a tardive syndrome arising in the setting of phentermine use (1). Phentermine is an amphetamine and can potentially lead to dopamine depletion. This case illustrates the potential for tardive syndromes associated with stimulant use. While atypical, it is important to recognize the potential occurrence of this side effect. Additionally, it is possible that his parkinsonism represented either an unmasking of idiopathic Parkinson’s Disease or a drug-induced phenomenon. We will discuss diagnostic possibilities and treatment of both movement disorders.

References: 1. Tan EK, Jankovic J. Tardive and idiopathic oromandibular dystonia: A clinical comparison. J Neurol Neurosurg Psychiatry. 2000;68(2):186-190. doi:10.1136/jnnp.68.2.186.

To cite this abstract in AMA style:

R. Barmore, C. Hess, N. McFarland, M. Okun. A case of tardive dyskinesia and parkinsonism following use of phentermine for weight loss [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/a-case-of-tardive-dyskinesia-and-parkinsonism-following-use-of-phentermine-for-weight-loss/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-case-of-tardive-dyskinesia-and-parkinsonism-following-use-of-phentermine-for-weight-loss/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley